Life Sciences
Use a strategic, well-planned approach to become serialization-ready.
It's time to develop an M&A playbook that addresses people, processes, technology, and culture.
Executing on an integrated strategy with the key customers - the physicians, payers, and patients
Arguably the biggest challenge facing Life Science companies today is the ‘patent cliff’, and the increased difficulty companies are facing replacing their highly profitable blockbuster drugs. Bringing new products from discovery to market is becoming ever more expensive, and ‘me-too’ products have lost their charm. In response, Life Sciences companies are increasingly faced with the need to improve supply chains, enhance their operating efficiencies, and protect and improve profit margins. At the same time, the Life Sciences market is experiencing a decrease in consumer confidence and an increase in government regulations. Companies seeking to protect their brand name, company reputation, shareholder confidence and patient safety must develop a flexible, agile strategy to stay on top of emerging standards and comply with complex global regulatory requirements.
 Pharmaceutical Sales Force Transformation: Meeting The Human Capital Challenge » |
 Case Study: Working with Alexion Pharmaceutical to build foundations for future growth with SAP » |
Clarkston Consulting has worked closely with more than half of the world’s top 50 Life Sciences market leaders. Our highly skilled consultants average more than 15 years of industry and consulting experience. In Life Sciences, Clarkston primarily focuses its expertise within the industries of pharmaceutical, biotech, and medical devices, chemicals and intermediates, consumer health (OTC), and product suppliers. Our strengths include these four core areas:
- Improving Demand Practices
- Supply Chain Management
- Quality Systems & Regulatory Compliance
- Enterprise Systems
